After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Spyre Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Spyre Therapeutics Inc is $1.41B. A total of 0.48 million shares were traded on the day, compared to an average of 546.75K shares.
In the most recent transaction, Albers Jeffrey W. sold 6,700 shares of SYRE for 36.76 per share on Nov 06 ’24. After the transaction, the Director now owns 27,360 company shares. In a previous transaction on Oct 25 ’24, Albers Jeffrey W. sold 300 shares at 36.43 per share. SYRE shares that Director owns now total 34,060.
Among the insiders who bought shares, SESSIONS, LLC acquired of 7,000 shares on Oct 25 ’24 at a per-share price of $33.70. In another insider transaction, Burrows Scott L sold 18,531 shares at $28.17 per share on Sep 03 ’24. Company shares held by the Chief Financial Officer now total 116,422.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, SYRE has a high of $47.97 and a low of $20.07.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. SYRE’s latest balance sheet shows that the firm has $93.13M in Cash & Short Term Investments as of fiscal 2021. There were $5.06M in debt and $20.14M in liabilities at the time. Its Book Value Per Share was $3.34, while its Total Shareholder’s Equity was $83.94M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SYRE is Buy with a score of 4.82.
